课题基金 / 基金详情

SALESFORCE LICENSES

SALESFORCE LICENSES
销售人员许可证
批准号:
10721228
负责人:
ELYSE SERAFIN
金额:
$31.92万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-08-15 至 2023-08-14

项目摘要

项目成果

ELYSE SERAFIN的其他基金

相似基金

相关文献

中文摘要
翻译
NHLBI/OM/ITAC继续使用Salesforce许可证(DOCS和恩智浦应用程序),为全球领导者提供研究、培训和教育计划,以促进心、肺和血液疾病的预防和治疗,并增强所有人的健康。它与包括学术机构、行业和其他政府机构在内的私营和公共组织合作,创建并支持强大的协作研究基础设施。其目标是提供NHLBI IOD和OSPEEC通信管理,以更准确、更高效地参与并改进对利益相关者和个人的服务,通过利用基于Salesforce的系统来降低技术成本。
英文摘要
NHLBI / OM / ITAC continues to use Salesforce licenses (DOCS and NXP applications) to provide to the global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals. It creates and supports a robust, collaborative research infrastructure in partnership with private and public organizations, including academic institutions, industry, and other government agencies. The goal is to provide the NHLBI IOD and the OSPEEC correspondence management that engages and improves service to stakeholders and individuals more accurately and efficiently, reducing technology costs by utilizing a system built on Salesforce.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SALESFORCE LICENSES
  • 批准号:
    10901809
  • 项目类别:
  • 资助金额:
    $33.04万
  • 财政年份:
    2023
  • 负责人:
    ELYSE SERAFIN
  • 依托单位:
海外基金